Humana Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Humana han disminuido a una tasa media anual de -2.5%, mientras que en la industria Healthcare los beneficios crecieron en un 31.9% anualmente. Los ingresos han ido creciendo a una tasa media de 7.1% al año. La rentabilidad financiera de Humana es de 5%, y sus márgenes netos son de 1.5%.

Información clave

-2.5%

Tasa de crecimiento de los beneficios

0.2%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	8.1%
Tasa de crecimiento de los ingresos	7.1%
Rentabilidad financiera	5.0%
Margen neto	1.5%
Próxima actualización de resultados	19 Jul 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Humana AB (publ) (STO:HUM) Doing What It Can To Lift Shares

Apr 09

Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think

Feb 12

Humana AB (publ)'s (STO:HUM) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 11

Did Humana AB (publ) (STO:HUM) Insiders Buy Up More Shares?

Feb 28

Do Humana's (STO:HUM) Earnings Warrant Your Attention?

Feb 15

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Humana. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

OM:HUM Ingresos, gastos y beneficios (SEK Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Mar 24	9,621	146	1,177
31 Dec 23	9,649	176	1,200
30 Sep 23	9,684	228	1,211
30 Jun 23	9,659	250	1,176
31 Mar 23	9,491	232	1,122
31 Dec 22	9,203	210	1,082
30 Sep 22	8,869	183	1,037
30 Jun 22	8,530	203	988
31 Mar 22	8,347	242	963
31 Dec 21	8,186	276	926
30 Sep 21	8,000	293	891
30 Jun 21	7,896	279	896
31 Mar 21	7,825	272	902
31 Dec 20	7,771	262	913
30 Sep 20	7,750	230	86
30 Jun 20	7,739	249	104
31 Mar 20	7,670	197	113
31 Dec 19	7,446	188	89
30 Sep 19	7,247	222	-57
30 Jun 19	7,005	196	-34
31 Mar 19	6,774	245	-21
31 Dec 18	6,714	246	25
30 Sep 18	6,600	228	239
30 Jun 18	6,550	197	226
31 Mar 18	6,541	199	218
31 Dec 17	6,542	194	212
30 Sep 17	6,635	195	279
30 Jun 17	6,684	241	287
31 Mar 17	6,540	226	263
31 Dec 16	6,362	148	218
30 Sep 16	6,140	139	288
30 Jun 16	5,868	-11	230
31 Mar 16	5,713	-53	185
31 Dec 15	5,593	28	157
31 Dec 14	5,065	38	129
31 Dec 13	3,489	111	58

Ingresos de calidad: HUM tiene un gran one-off gain de SEK76.0M impacto en sus últimos 12 meses de resultados financieros a 31st March, 2024.

Margen de beneficios creciente: Los actuales márgenes de beneficio(1.5%) de HUM son inferiores a los del año pasado (2.4%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de HUM han disminuido en un 2.5% al año en los últimos 5 años.

Acelerando crecimiento: HUM ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: HUM tuvo un crecimiento negativo de los beneficios (-37.1%) durante el año pasado, lo que dificulta la comparación con la media de la industria Healthcare (9%).

Humana Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

First quarter 2024 earnings released: EPS: kr0.44 (vs kr1.07 in 1Q 2023)

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana AB (publ) to Report Fiscal Year 2023 Results on Apr 03, 2024

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Humana AB (publ) to Report Q4, 2023 Results on Feb 08, 2024

Recent updates

First quarter 2024 earnings released: EPS: kr0.44 (vs kr1.07 in 1Q 2023)

Investor sentiment improves as stock rises 15%

Humana AB (publ) (STO:HUM) Doing What It Can To Lift Shares

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana AB (Publ) Announces Nomination Committee for the Annual General Meeting 2024

Humana Announces Board Changes, Effective May 1, 2024

Consensus revenue estimates increase by 11%, EPS downgraded

Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana Announces the Resignation of Johanna Rastad as President

Humana AB (publ) to Report Fiscal Year 2023 Results on Apr 03, 2024

New major risk - Revenue and earnings growth

Consensus EPS estimates increase by 15%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Humana AB (publ), Annual General Meeting, May 07, 2024

Humana AB (publ) to Report Q4, 2023 Results on Feb 08, 2024

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 23%

Price target increased by 41% to kr23.50

New major risk - Share price stability

Investor sentiment improves as stock rises 42%

Humana AB (publ) Announces Board Appointments

Full year 2022 earnings: EPS exceeds analyst expectations

Investor sentiment improves as stock rises 16%

Does Humana (STO:HUM) Have A Healthy Balance Sheet?

Full year 2022 earnings: EPS exceeds analyst expectations

Sören Mellstig Not Stands for the Re-Election to the Board of Humana AB (Publ)

Price target decreased by 23% to kr45.67

Humana AB (publ) to Report Fiscal Year 2022 Results on Apr 03, 2023

At kr20.50, Is It Time To Put Humana AB (publ) (STO:HUM) On Your Watch List?

Investor sentiment deteriorates as stock falls 50%

Humana AB (publ) to Report Nine Months, 2023 Results on Nov 09, 2023

Price target decreased by 7.8% to kr59.33

Price target decreased to kr60.33

Humana AB (Publ) Announces Management Changes

Price target decreased to kr64.33

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana AB (publ) to Report Q1, 2023 Results on May 04, 2023

Sön Mellllstig, Chairman of the Board of Humana Ab, Is Not Available for Re-Election at the 2023 Annual General Meeting

Is Humana (STO:HUM) Using Too Much Debt?

Humana AB Announces Nomination Committee for 2023 AGM

Consensus forecasts updated

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Independent Chairman of the Board recently bought kr38m worth of stock

Noora Jayasekara Leaves Humana Member of Group Management

Humana AB (publ) (OM:HUM) acquired Vintergatan AB.

Humana AB (publ) (OM:HUM) completed the acquistion of Assistans For Dig I Sverige Ab.

Humana AB (publ) (OM:HUM) agreed to acquire Assistans For Dig I Sverige Ab for approximately SEK151 million.

Price target decreased to kr79.00

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to kr81.50

Full year 2021 earnings: Revenues in line with analyst expectations

Is It Too Late To Consider Buying Humana AB (publ) (STO:HUM)?

Humana AB (publ) to Report Q3, 2022 Results on Nov 10, 2022

President & CEO recently bought kr180k worth of stock

President & CEO recently bought kr200k worth of stock

Consensus EPS estimates fall by 11%

Price target decreased to kr86.50

Full year 2021 earnings: EPS misses analyst expectations

Investor sentiment deteriorated over the past week

Now 24% undervalued after recent price drop

Humana AB (publ) (OM:HUM) acquired Kalliola Oy - Uudet Setlementtiratkaisut.

Is Humana (STO:HUM) Using Too Much Debt?

Third quarter 2021 earnings released: EPS kr2.54 (vs kr2.05 in 3Q 2020)

Price target increased to kr97.50

Director of Marketing & Communication Helena Pharmanson has left the company

Director of Human Resources Anna Skablova has left the company

Desglose de ingresos y gastos
Beta